-
Notifications
You must be signed in to change notification settings - Fork 0
Commit
This commit does not belong to any branch on this repository, and may belong to a fork outside of the repository.
Add: create new questions for bronchiectasis management, pneumonia se…
…verity, and pulmonary hypertension; update tags for existing questions
- Loading branch information
Showing
5 changed files
with
124 additions
and
2 deletions.
There are no files selected for viewing
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Original file line number | Diff line number | Diff line change |
---|---|---|
@@ -0,0 +1,39 @@ | ||
--- | ||
id: PULM007 | ||
specialty: pulmonology | ||
topic: bronchiectasis | ||
difficulty: medium | ||
tags: [respiratory, chronicCare, imaging, copilotO1] | ||
created: 2025-01-02 | ||
lastUpdated: 2025-01-02 | ||
--- | ||
|
||
# Bronchiectasis Management | ||
|
||
## Question | ||
A 50-year-old patient with chronic productive cough and recurrent infections on CT shows dilated bronchi with thickened walls. Sputum grows Pseudomonas aeruginosa. Which therapy is most appropriate? | ||
|
||
## Options | ||
| Option | Description | | ||
|--------|---------------------------------------| | ||
| A) | Chest physiotherapy + inhaled tobramycin | | ||
| B) | Oral steroids indefinitely | | ||
| C) | Only supportive oxygen | | ||
| D) | Immediate lobectomy | | ||
| E) | Macrolide monotherapy for 2 weeks | | ||
|
||
<details> | ||
<summary>View Answer</summary> | ||
|
||
## Correct Answer | ||
A | ||
|
||
## Explanation | ||
1. Airway clearance plus inhaled antibiotics is standard for Pseudomonas. | ||
2. Chronic oral steroids (B) not first-line. | ||
3. Lobectomy (D) only for localized, refractory disease. | ||
|
||
## References | ||
- ERS Guidelines for Bronchiectasis 2021 | ||
- NEJM 2018: "Bronchiectasis Management" | ||
</details> |
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Original file line number | Diff line number | Diff line change |
---|---|---|
@@ -0,0 +1,44 @@ | ||
--- | ||
id: PULM006 | ||
specialty: pulmonology | ||
topic: pneumonia | ||
difficulty: medium | ||
tags: [respiratory, treatment, clinicalCase, copilotO1] | ||
created: 2025-01-02 | ||
lastUpdated: 2025-01-02 | ||
--- | ||
|
||
# Community-Acquired Pneumonia Severity | ||
|
||
## Question | ||
A 67-year-old man presents with pneumonia symptoms: | ||
- RR: 30/min | ||
- BP: 90/58 mmHg | ||
- Confusion | ||
- Elevated urea | ||
He has a CURB-65 score of 3. Which management is most appropriate? | ||
|
||
## Options | ||
| Option | Description | | ||
|--------|-------------------------------------------------| | ||
| A) | Outpatient antibiotics + follow-up | | ||
| B) | Oral macrolide + decongestants | | ||
| C) | IV ceftriaxone + azithromycin, admit to hospital | | ||
| D) | High-dose IV vancomycin + linezolid | | ||
| E) | Supportive care only | | ||
|
||
<details> | ||
<summary>View Answer</summary> | ||
|
||
## Correct Answer | ||
C | ||
|
||
## Explanation | ||
1. CURB-65 score ≥3 indicates high risk. | ||
2. Admission with IV antibiotics recommended. | ||
3. Vancomycin or linezolid (D) reserved for MRSA suspicion. | ||
|
||
## References | ||
- NICE Pneumonia Guidelines 2023 | ||
- IDSA/ATS CAP Guidelines | ||
</details> |
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Original file line number | Diff line number | Diff line change |
---|---|---|
@@ -0,0 +1,39 @@ | ||
--- | ||
id: PULM008 | ||
specialty: pulmonology | ||
topic: pulmonary-hypertension | ||
difficulty: hard | ||
tags: [respiratory, chronicCare, cardiovascular, copilotO1] | ||
created: 2025-01-02 | ||
lastUpdated: 2025-01-02 | ||
--- | ||
|
||
# Pulmonary Hypertension Management | ||
|
||
## Question | ||
A 42-year-old woman with dyspnea on exertion undergoes right heart catheterization confirming pulmonary arterial hypertension (PAH). Which specific therapy is most appropriate? | ||
|
||
## Options | ||
| Option | Description | | ||
|--------|-----------------------------------------------------------------| | ||
| A) | High-dose diuretics + vasopressors | | ||
| B) | Prostacyclin analog (epoprostenol) infusion | | ||
| C) | Beta-2 agonists + inhaled corticosteroids | | ||
| D) | Empiric antibiotics + chest physiotherapy | | ||
| E) | Oral nitrate plus digoxin | | ||
|
||
<details> | ||
<summary>View Answer</summary> | ||
|
||
## Correct Answer | ||
B | ||
|
||
## Explanation | ||
1. PAH often requires targeted vasodilator therapy: prostanoids, PDE5 inhibitors, or endothelin receptor antagonists. | ||
2. Epoprostenol improves outcomes in severe PAH. | ||
3. Diuretics can help volume overload but are not definitive. | ||
|
||
## References | ||
- CHEST 2022: "Pulmonary Arterial Hypertension Update" | ||
- NEJM 2021: "Advances in PAH Treatment" | ||
</details> |